Scholars Central

Conference abstractPublished 5 Aug 2013

Genomic analysis for early indication of cochlear implantation

Authors: Hans Peter Zenner

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Molecular personalized medicine has to goal, to identify those patients, who respond in a positive or negative (non-responder, no wanted effect) manner to a specific therapy. Using genomic analyses of the functional proteins otoferlin, connexin26, KCNQ4 or Usher genes personalized plays an increasing role in the indication of cochlear implants for newborn babies. Instead of waiting for a non-development of language, application allows for early implantation and thus for earlier language development.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalTranslational Medicine
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Hans Peter Zenner”